You can watch Inventiva and buy or sell other stocks, options, and ETFs commission-free!
Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors.
52 Week High
52 Week Low
— per share
Available Sep 20, After Hours